Trial Profile
A 6-Week, Randomized, Open-Label, Comparative Study to Evaluate the Efficacy and Safety of Rosuvastatin and Atorvastatin in the Treatment of Hypercholesterolaemia in South Asian Subjects
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Apr 2008
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary) ; Atorvastatin
- Indications Hypercholesterolaemia; Hyperlipidaemia
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms IRIS
- Sponsors AstraZeneca
- 17 Apr 2008 New trial record.